iRhythm Zio Patch

By Dave Muoio November 15, 2017
Connected wearable patch makers will ship 35.1 million units annually by 2022, with 80 percent of these being used in clinical applications, according to a recent report from market intelligence firm Tractica. The report also forecasts a total $7.9 billion in revenue for the patch market by the same year, all of which suggests a substantial escalation from the 966,000 units the analysts wrote...
By Jonah Comstock July 11, 2017
A team of researchers from Stanford University, working with cardiac monitoring company iRhythm, have created an AI algorithm that, in a small proof-of-concept trial, outperformed board-certified cardiologists at identifying various types of arrhythmias from ECGs. The results have been published to arXiv, an online archive for scientific papers, but have not yet appeared in a peer-reviewed...
By Jonah Comstock September 26, 2016
iRhythm, maker of the wearable-and-wireless-but-not-connected Zio heart rate monitoring system, has filed with the SEC to raise up to $86 million in an initial public offering.  The Zio patch, iRhythm's sole product as of now, is a small wearable sensor, used for multi-day monitoring of arrhythmias in cardiac patients (up to a fortnight). Unlike many participants in that space, however, the...
By Jonah Comstock May 22, 2014
iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture Partners also participated in the round. This brings the company's total disclosed funding to about $85 million, based on SEC filings and company announcements. As part of the latest investment deal...
By Jonah Comstock May 5, 2014
Tel Aviv, Israel-based HealthWatch is working on another entry for the still emerging smart textile field. At the American Telemedicine Association conference in Baltimore, Maryland, the startup previewed its hWear line of tshirts with interwoven ECG sensors, allowing the shirt to function as a 3 to 15 lead ECG. "A cardiologist will not formally diagnose a heart attack until you’ve taken a 12-...
By Brian Dolan August 14, 2012
August is not yet half over and already the FDA has had a busy summer. In recent weeks MobiHealthNews reported on the FDA's de novo clearance of Proteus Digital Health's intelligent medicine platform and Asthmapolis' inhaler sensor and companion software. As we noted early last month, the FDA granted 510(k) clearance to a variety of digital health companies in June, including the app-enabled...